References
- Chio A., Mora G., Leone M., Mazzini L., Cocito D., Giordana M. T., et al. Early symptom progression rate is related to ALS outcome: a prospective population‐based study. Neurology 2002; 59: 99–103
- Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
- Ringel S. P., Murphy J. R., Alderson M. K., Bryan W., England J. D., Miller R. G., et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 43: 1316–22
- Cedarbaum J. M., Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 1997; 152((Suppl 1))S1–9
- Kaufmann P., Levy G., Thompson J. L. P., DelBene M. L., Battista V., Gordon P. H., et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005; 64: 38–43
- del Aguila M. A., Longstreth W. T., Jr., McGuire V., Koepsell T. D., van Belle G. Prognosis in amyotrophic lateral sclerosis: a population‐based study. Neurology 2003; 60: 813–9
- Louwerse E. S., Visser C. E., Bossuyt P. M., Weverling G. J., The Netherlands ALS Consortium. Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. J Neurol Sci 1997; 152((Suppl 1))S10–7